236 related articles for article (PubMed ID: 17369580)
21. Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.
Cao Y; Wu L; Tan A; Liu L; Liao C; Gao F
Pancreas; 2010 Mar; 39(2):253-5. PubMed ID: 20182311
[No Abstract] [Full Text] [Related]
22. [Experience with the treatment of advanced pancreatic cancer in Hungary].
Bodoky G
Magy Onkol; 2003; 47(2):194-7. PubMed ID: 12975669
[TBL] [Abstract][Full Text] [Related]
23. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
24. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
Martenson JA; Vigliotti AP; Pitot HC; Geeraerts LH; Sargent DJ; Haddock MG; Ghosh C; Keppen MD; Fitch TR; Goldberg RM
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1305-10. PubMed ID: 12654442
[TBL] [Abstract][Full Text] [Related]
25. Novel approaches to postoperative chemoradiation therapy in pancreatic cancer.
Picozzi VJ
J Gastrointest Surg; 2001; 5(1):8-9. PubMed ID: 11370619
[No Abstract] [Full Text] [Related]
26. [Present and future home therapy in advanced stage of pancreatic cancer].
Funakoshi A; Sumii T
Gan To Kagaku Ryoho; 2006 May; 33(5):602-5. PubMed ID: 16685156
[TBL] [Abstract][Full Text] [Related]
27. Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical development.
Tabernero J; Macarulla T
J Clin Oncol; 2009 Nov; 27(33):5487-91. PubMed ID: 19858387
[No Abstract] [Full Text] [Related]
28. Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer.
Rauch DP; Maurer CA; Aebi S; Pampallona S; Friess H; Ludwig CU; Büchler MW; Borner MM
Oncology; 2001; 60(1):43-8. PubMed ID: 11150907
[TBL] [Abstract][Full Text] [Related]
29. Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer.
Arshad A; Al-Leswas D; Al-Taan O; Stephenson J; Metcalfe M; Steward WP; Dennison AR
Am J Clin Oncol; 2013 Aug; 36(4):411-4. PubMed ID: 21436672
[TBL] [Abstract][Full Text] [Related]
30. Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.
Feliu J; Sáenz JG; Jaráiz AR; Castañón C; Cruz M; Fonseca E; Lomas M; Castro J; Jara C; Casado E; León A; Barón MG
Cancer Chemother Pharmacol; 2006 Oct; 58(4):419-26. PubMed ID: 16404636
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer.
Brodowicz T; Wolfram RM; Köstler WJ; Tomek S; Vaclavik I; Steger GG; Teleky B; Függer R; Jakesz R; Zielinski CC
Anticancer Drugs; 2000 Sep; 11(8):623-8. PubMed ID: 11081453
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.
Richards DA
Semin Oncol; 2005 Aug; 32(4 Suppl 6):S9-13. PubMed ID: 16143162
[TBL] [Abstract][Full Text] [Related]
33. A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S; Gasparini G; Catalano V; Silva RR; Pancera G; Morabito A; Giordani P; Gattuso D; Catalano G
Ann Oncol; 1999 Nov; 10(11):1377-9. PubMed ID: 10631469
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
El-Rayes BF; Zalupski MM; Shields AF; Ferris AM; Vaishampayan U; Heilbrun LK; Venkatramanamoorthy R; Adsay V; Philip PA
Invest New Drugs; 2005 Dec; 23(6):583-90. PubMed ID: 16034525
[TBL] [Abstract][Full Text] [Related]
35. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Heinemann V
J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
[No Abstract] [Full Text] [Related]
36. Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.
Rivera F; López-Tarruella S; Vega-Villegas ME; Salcedo M
Cancer Treat Rev; 2009 Jun; 35(4):335-9. PubMed ID: 19131170
[TBL] [Abstract][Full Text] [Related]
37. [Role of gemcitabine/cisplatin in the treatment of advanced and metastatic bladder cancer].
Bodrogi I
Magy Onkol; 2003; 47(2):198-203. PubMed ID: 12975670
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.
Ueno H; Okusaka T; Ikeda M; Morizane C; Ogura T; Hagihara A; Tanaka T
Jpn J Clin Oncol; 2007 Jul; 37(7):515-20. PubMed ID: 17675286
[TBL] [Abstract][Full Text] [Related]
39. [Recent important insights into treatment of pancreatic cancer].
Abe N; Sugiyama M; Atomi Y
Gan To Kagaku Ryoho; 2005 May; 32(5):617-23. PubMed ID: 15918560
[TBL] [Abstract][Full Text] [Related]
40. [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].
Nakamura N; Teramoto K; Arii S
Nihon Rinsho; 2006 Jan; 64 Suppl 1():534-8. PubMed ID: 16457320
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
